Merck & Co., Inc. (MRK) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-02 (expected, time not announced). EPS estimate 1.78, revenue estimate 16.29B.
Over the last 12 reports the stock moved 4.4% on average (either way), rising 7 times and falling 5. EPS beat estimates 11 of 12 times; revenue 11 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-29 | 2.49 | 2.09 | +19.1% | 18.09B | 17.33B | +6.1% |
| Q2 FY2026 | 2026-08-04 | -0.13 | -0.27 | +51.9% | 16.61B | 16.37B | +0.4% |
| Q1 FY2026 | 2026-04-30 | -1.28 | -1.47 | +12.9% | 16.29B | 15.85B | +1.1% |
| Q4 FY2025 | 2026-02-03 | 2.04 | 2.01 | +1.5% | 16.40B | 16.20B | +4.4% |
| Q3 FY2025 | 2025-10-30 | 2.58 | 2.36 | +9.3% | 17.28B | 16.98B | -0.7% |
| Q2 FY2025 | 2025-07-29 | 2.13 | 2.03 | +4.9% | 15.81B | 15.86B | -2.7% |
| Q1 FY2025 | 2025-04-24 | 2.22 | 2.13 | +4.2% | 15.53B | 15.34B | +5.1% |
| Q4 FY2024 | 2025-02-04 | 1.72 | 1.85 | -7.0% | 15.62B | 15.48B | -10.1% |